Clinical trials in Feltre

2 clinical trials in Feltre, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Feltre at a glance

clinical trials

Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

2 trials in Feltre

Open in trial search

Chronic kidney disease

Recruiting

Registered drug

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Azd5004
Sponsor:AstraZeneca AB

Contact Research Centre

Non-small cell lung cancer stage IV

Recruiting

Registered drugNo placebo

Study Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Fondazione Ricerca Traslazionale

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Feltre

What the registry says about research in the country

01 Feltre

Neoplasms and Oncology

Clinical research in Feltre includes studies focused on advanced non-small-cell lung cancer, with attention on improving outcomes for people starting treatment for this aggressive disease. These trials are exploring whether combining targeted cancer therapies can offer better disease control and longer survival. Testing new treatment approaches for advanced non-small-cell lung cancer Evaluating whether combination therapy can improve overall survival Supporting better first-line care for patients with PD-L1 high metastatic NSCLC The work reflects a broader effort to refine cancer treatment strategies and make therapies more effective for patients in routine care.

Reproductive and Urinary Physiological Phenomena and Kidney Disease

Another active area of research in Feltre is chronic kidney disease, where trials are studying ways to slow progression and reduce serious heart-related complications. The goal is to strengthen heart and kidney protection through better treatment combinations. Studying new options for people with chronic kidney disease Assessing whether treatment can prevent worsening kidney function Looking at reductions in hospitalisation for heart failure and cardiovascular death These studies aim to improve long-term management for patients living with kidney disease and related cardiovascular risks.

Back to Italy All countries